Transcriptomics

Dataset Information

27

Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma


ABSTRACT: Recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) remains one of the most difficult cancers to treat with limited chemotherapeutic options. Here, we describe a patient with HNSCC who had complete response to methotrexate (MTX) after progressing on multiple cytotoxic agents; cetuximab, a monoclonal antibody (mAb) against Epidermal Growth Factor Receptor (EGFR), and AMG 479, a mAb against Insulin-like Growth Factor-1 Receptor (IGF-1R). In tumor tissue of this patient we observed gene expression modulation by cetuximab and AMG 479 suggesting crosstalk between the EGFR and IGF-1R pathways that may have sensitized the tumor to MTX. This represents a promising novel approach to development of targeted agents in refractory cancer. Keywords: tumor response Overall design: 10 samples from different time points during course of treatment in a single individual.

INSTRUMENT(S): [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Christine H. Chung  

PROVIDER: GSE9600 | GEO | 2010-08-03

SECONDARY ACCESSION(S): PRJNA103447

REPOSITORIES: GEO

Similar Datasets

2010-08-03 | E-GEOD-9600 | ArrayExpress
2016-03-22 | E-GEOD-67500 | ArrayExpress
| GSE63916 | GEO
2012-05-22 | E-GEOD-32975 | ArrayExpress
| GSE62027 | GEO
2010-08-25 | GSE23792 | GEO
2010-08-25 | E-GEOD-23792 | ArrayExpress
2014-09-18 | E-GEOD-61495 | ArrayExpress
| GSE80667 | GEO
| GSE80399 | GEO